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Abstract 
This study was aimed at determing the possible effects of obesity and glycaemic control on serum Chromium, Zinc, 
and Testosterone levels in diabetics and non-diabetic subjects. Twenty five (25) diabetics aged between 35-68years 
and thirty nine (39) non-diabetics aged matched were investigated for Serum Chromium, Zinc, and Testosterone, and 
Fasting Plasma glucose and glycosylated haemoglobin using standard methods. Body Mass indices of subjects were 
also determined.  The result shows that Serum zinc levels in diabetics were significantly higher when compared with 
the non-diabetics (p<0.05) while serum testosterone was significantly lower in obese non-diabetics and obese 
diabetics with poor glycaemic control when compared to their non-obese counterparts (p<0.05). Serum zinc 
correlated positively with fasting plasma glucose in non-obese non-diabetics (r=0.4388, p<0.05) while Serum 
chromium correlated positively with glycosylated haemoglobin in obese diabetics (r=0.9877, p<0.05). Serum 
testosterone correlated negatively with serum zinc in obese diabetics, and with fasting plasma glucose in obese non-
diabetics respectively (r=-0.9639, r=-0.7364, p<0.05) while a negative correlation was observed between fasting 
plasma glucose and glycosylated haemoglobin in diabetics (r=0.3830, p<0.05). In conclusion, Obesity and the 
control of diabetes did influence serum testosterone levels. Serum chromium and zinc levels were observed to be 
altered in diabetes mellitus condition. 
Key words: chromium, zinc, testosterone.  
Introduction 
Diabetes mellitus is a group of metabolic diseases characterized by hyperglycaemia resulting from defects in insulin 
secretion, action or both (Freeman, 2010). Research evidence has associated low testosterone levels, zinc and 
chromium deficiencies mainly with type 2 diabetes (Clements, 2010).  Type 2 Diabetes is associated with chronic 
hyperglycaemia which damages blood vessels and nerve cells throughout the body, producing micro-vascular 
diseases as well as increased risk of cardiovascular diseases. As a consequence, type 2 Diabetes represents a major 
public health problem that causes high economic costs in industrialized countries (Kazi, 2008). Chronic 
hyperglycaemia may cause significant alterations in the status of some micronutrients resulting in deficiencies of 
certain minerals such as magnesium, zinc and chromium which leads to glucose intolerance and development of 
diabetic complications ((Zargar et al., 1998, Chen et al., 1995). Zinc is implicated in the improvement of insulin 
sensitivity and guards against diabetes, inhibits aromatase responsible for the conversion of testosterone to estrogen, 
improves sex drive and semen volume by enhancing the conversion of androstenedione into forms of testosterone 
(Clements, 2010) while chromium is essential for normal sugar metabolism (Reavley, 2009). Life style, medication, 
disease and ageing process have been found to contribute to the gradual and progressive decline in serum 
testosterone levels during life, as a result of a primary testicular and secondary hypothalamo-pituitary dysfunction 
(Harman et al, 2001).  The aim of this study is to assay the serum levels of chromium, zinc and testosterone and their 
association with glycaemic status in diabetic and non-diabetic subjects in Calabar Nigeria.  
 
Materials and Methods 
A total of sixty four (64) subjects were enrolled into this study. Twenty five (25) of them were known type 2 diabetic 
subjects who were all Nigerians aged 30 – 68 years attending the University of Calabar Teaching Hospital diabetic 
clinic (UCTH) Calabar and thirty nine (39)  age-matched apparently healthy individuals from the general population 
whose blood glucose levels were below 5mmol/l  were used as control subjects in this research. Their weights and 
heights were taken and was used to compute their body mass index (BMI) which was used to classify the diabetics 
and non-diabetics into obese (≥30 kg/m
2
) and non-obese (≤29.9 kg/m
2
) groups (Yoneda et al., 1998). Structured 
questionnaire was used to obtain data on occupation, physical activity, diet, past and present illness and medication.
  
Ten millilitres of fasting venous blood samples were collected aseptically from the subjects and placed into 
appropriate sample bottles. Two millilitres was placed in 0.1ml of fluoride oxalate for fasting plasma glucose, three 
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millilitres into 0.08ml of sequesterene for glycosylated haemoglobin and five millilitres into plain bottle for serum 
chromium, zinc, and testosterone. Standard methods of Trinder, 1969 and Trivelli, 1971 were used for fasting plasma 
glucose and glycosylated haemoglobin estimations respectively. ELISA kit method purchased from DRG 
Instruments GmbH, Germany, was used for serum testosterone estimation while absorption spectrophotometric 
technique was used for the determination of serum chromium and zinc. The generated data were systematically 
analysed as appropriate for means, standard deviation, Student’s t-test, and Pearson’s correlation analysis on 
Microsoft excel and SPSS software version 18 (California Inc.). Results are presented as the Mean ± Standard 
deviation. A two sided P<0.05 was considered statistically significant for t-test (used to determine the differences 
between the groups) and Pearson’s correlation analysis, which was used to determine the inter-variable associations 
of the various groups (Armitage and Berry, 1994).  
 
Results 
Table 1 shows means for Age, body mass index (BMI), blood pressure, fasting plasma glucose (FPG), glycosylated 
haemoglobin (HbA1c), serum chromium, serum zinc, and testosterone levels of all the diabetics and non-diabetics 
enrolled in this study. The means of  fasting plasma glucose (9.71±4.66mmol/L), glycosylated haemoglobin 
(8.93±3.37%)  and zinc levels (97.33±12.16µg/dl) were significantly higher in diabetics when compared with non-
diabetics (4.78±1.14mmol/L, 5.80±1.19%, 88.54±15.17µg/dl) while  serum chromium levels (0.0032±0.0019µg/dl)  
were significantly lower in diabetics when compared with non-diabetic (0.0046±0.0021µg/dl) subjects.  Figure 1 
shows scatter plot of fasting plasma glucose against glycosylated haemoglobin in diabetics (r=-0.3830, p<0.05), 
figure 2 shows fasting plasma glucose against serum testosterone in non-diabetics(r=-0.7364, p<0.05), figure 3 
fasting plasma glucose against serum zinc in non-obese non-diabetics (r=0.4388, p<0.05), fig 4 illustrates serum 
chromium against glycosylated haemoglobin in obese diabetics (r=0.9877, p<0.05) and fig 5 serum testosterone 
against serum zinc in obese diabetics (r=-0.9639, p<0.05). 
 
Discussion 
      Medication adherence (Schectman et al., 2002), physical activity (Kirk et al., 2003), family support (Konen et 
al., 1993) and coping mechanisms (Turan et al., 2002) have been reported to correlate with glycaemic (diabetic) 
control. In the present study, glycosylated haemoglobin correlated negatively with fasting plasma glucose (fig.1-
moderate association).This appears to be so because; the subjects were poorly controlled diabetics. The finding is at 
par with report of Rosediani, et al. 2006 who worked on diabetic subjects with good glycaemic control 
(HbA1c<7%).  Serum zinc levels increased in diabetes mellitus condition (table1) and this is in line with Song’s, et 
al. (2000) report. The reason for this finding could be due to the imbalanced rate of absorption to excretion of zinc. 
Furthermore, serum zinc correlated positively with fasting plasma glucose in non-obese non-diabetics (fig3-moderate 
association). The absence of an upsurge of fasting plasma glucose prevents insulin secretion, thus, the level of fasting 
plasma glucose and zinc remains low and within the reference range in these subjects. In line with the report of 
Hemmati, et al., 2011, serum chromium level in diabetics was observed to be significantly lower compared to the 
non-diabetics (p<0.05) (table1). Chromium is said to be decreased in hyperglycaemia, hyperinsulinaemia, insulin 
resistance, osmotic diuresis resulting from glycosuria (Normuhammadi, et al., 2001). However serum chromium 
correlated positively with glycosylated haemoglobin in obese diabetics (fig 4-strong association). Hyperinsulinemia 
due to obesity results in elevated serum chromium in the presence of hyperglycaemia which invariably results to 
increased glycosylated haemoglobin (Eckfeldt and Bruns, 1997). In accordance with the findings of Grossmann and 
his colleagues (2008), serum testosterone levels was significantly lower in obese non-diabetics as well as in obese 
diabetics with poor glycemic control compared to their non-obese counterparts (table 2). In Obesity, aromatase 
enzyme present in the fat cells, converts testosterone and androstenedione to estrogens, resulting in the depletion of 
testosterone in blood (Kapoor et al., 2005). Serum testosterone correlated negatively with fasting plasma glucose (fig 
2-strong association) in obese non-diabetics. Low sex-hormone binding globulin and serum testosterone predict 
higher glucose and insulin levels, and increased body mass index (Haffner et al., 1996).  Serum testosterone 
correlated negatively with serum zinc (fig 5-strong association) in obese diabetics. This is in line with a study 
reported by Koehler, et al. (2009) that increased serum zinc levels did not show any effect on testosterone levels 
which remained low as observed in this study.   
     In conclusion, the findings of this work have shown that the control of diabetes did not influence serum 
chromium, and serum zinc. Diabetes significantly influences the serum concentrations of chromium, and zinc except 
for the serum testosterone level. Obesity did not influence serum concentrations of chromium, and zinc except for 
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serum testosterone in obese diabetics with poor glycaemic control and in obese non-diabetics enrolled into the study. 
Therefore, for proper management of diabetes mellitus, adequate and timely use of hypoglycaemic agents and 
nutritional supplements should be emphasized and encouraged. 
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Table 1: Mean Age, Body Mass Index (BMI), Blood Pressure, Fasting Plasma Glucose (FPG), Glycosylated 
Haemoglobin (HbA1c), Serum Chromium, Zinc and Testosterone levels in Diabetics and non-diabetics in the 
University of Calabar Teaching Hospital. 
 
                                                                                                          Serum                                                                                Blood pressure             
Subjects  
Age 
(Years) 
BMI  
(Kg/m2) 
FPG 
(3.33-7.0 
mmol/L) 
HbA1c  
(6-8.3%) 
Chromium 
(0.005-0.05 
µg/dl) 
Zinc  
(70-120 
µg/dl) 
Testosterone                  
(3-10ng/ml)              
Systolic 
 (mmHg) 
Diastolic  
(mmHg) 
Non-
diabetics 
(n1=39) 48.85±9.20 26.87±4.99 4.78±1.14 5.80±1.19 0.0046±0.0021 88.54±15.17 8.03±3.79           40.23±20.38 83.33±13.88 
Diabetics  
(n2=25) 50.44±7.95 25.76±3.68 9.71±4.66 8.93±3.37 0.0032±0.0019 97.33±12.16 6.45±2.99 135.12±19.90 84.16±11.65 
P value P>0.05 P>0.05  P<0.05  P<0.05  P<0.05 P<0.05  P>0.05  P>0.05 P>0.05 
   
t-test analysis 
p<0.05 is significant 
p>0.05 is not significant  
n1= Number of non-diabetics  
n2= Number of diabetics 
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Table 2: Effect of obesity and diabetic control on the serum chromium, zinc, and testosterone concentrations 
in non-diabetic and diabetic Subjects (figures given as Means ± SD). 
                                                                        
Parameters             Groups                  Obese                      Non-obese                       P-value         Comment  
 Chromium       Non-diabetics       0.0048±0.0024 (n=12)     0.0044±0.0019 (n=27)      p>0.05               NS 
                         
 (µg/dl)                                  
                         Diabetics              0.0033±0.0020 (n=4)       0.0032±0.0020 (n=21)      p>0.05                NS 
       
                        Good control  
                         (HbA1c:6-8%)     0.0015±0.0007 (n=2)       0.0028±0.0017 (n=11)        p>0.05              NS    
                         Poor control  
                         (HbA1c:>8.3%)   0.0050±0.0000 (n=2)       0.0037±0.0022   (n=10 )     p>0.05              NS           
 
Zinc                 Non-diabetics       89.35±14.64 (n=12)         88.18±15.66 (n=27)              p>0.05            NS 
(µg/dl)             Diabetics               98.95±15.86 (n=4)           97.02±11.80 (n=21)              p>0.05            NS 
                        Good control 
                         (HbA1c:6-8%      94.73±26.00 (n=2)         96.56±10.80 (n=11)           p>0.05          NS             
                        Poor control 
                         (HbA1c:>8.3%)   103.81±2.82 (n=2)        97.53±13.39 (n=10)            p>0.05          NS      
 
Testosterone    Non-diabetics       6.06±2.38 (n=12)             8.90±4.01 (n=27)                  p<0.05            S 
(ng/ml)            Diabetics               5.35±2.94 (n=4)               6.66±3.02 (n=21)                  p>0.05           NS 
                        Good control  
                         (HbA1c:6-8%)     6.55±4.45 (n=2)             6.16±2.90 (n=11)               p>0.05           NS 
                        Poor control  
                         (HbA1c:>8.3%)   4.15±0.49 (n=2)             7.21±3.21 (n=10)               p<0.05           S 
 
n = Number of subjects for diabetics and non-diabetics.  
NS = Non-significant 
S = Signifinant 
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Fig 1: Correlation plot of glycosylated haemoglobin (HbA1c) against fasting plasma glucose (FPG) in 
diabetics. 
 
 
Fig 2: Correlation plot of serum testosterone against fasting plasma glucose (FPG) in obese non-diabetics. 
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Fig 3: Correlation plot of serum zinc against fasting plasma glucose (FPG) in non-obese non-diabetics. 
 
 
Fig. 4: Correlation plot of serum chromium (Cr) against glycosylated haemoglobin (HbA1c) in obese diabetics. 
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Fig 5: Correlation plot of serum testosterone against serum zinc (Zn) in obese diabetics. 
 
 
  
y = -0.1784x + 22.998
R² = 0.929
r=-0.9639
p<0.05
n=4
0.00
2.00
4.00
6.00
8.00
10.00
12.00
0 20 40 60 80 100 120
T
e
st
o
st
e
ro
n
e
 (
n
g
/m
l)
Zinc (µg/dl)
